- AU$278.59m
- AU$473.68m
- AU$269.46m
Brief: Monash IVF Group Announces Settlement Of Ni-PGT Class Action
Brief: Monash IVF Says Anticipating Revenue And Underlying NPAT Growth In FY25
Australia's Monash IVF slumps as class action settlement dents statutory profit
Brief: Monash IVF Group Posts FY Net Income A$5.949 Mln
Macquarie says CSL, Resmed most preferred among Australian healthcare firms
Brief: Monash IVF Group Announces Interim Dividend Of 2.5 AU Cents Per Share
Brief: Monash IVF Group Says FY24 Underlying Group NPAT Expected To Between A$29.0 Mln And A$30.0 Mln
Australia's Monash IVF Group up; Macquarie boosts PT to Street high
Jefferies, Macquarie favour Australia's Monash IVF's Fertility North acquisition
Jefferies sees Monash IVF's Fertility North acquisition profitable, raises PT
Brief: Monash IVF To Expand Its Presence In Perth IVF Market Via Acquisition
Australia's Monash slips; Macquarie positive on IVF industry, raises forecast
Brief: Monash IVF Group Says Is Confident Revenue And Earnings To Grow In 2H24 Compared To 2H23
Brief: Monash IVF Group Says Confident Current Industry Activity Will Continue To Grow In FY24
Brief: Monash IVF Group Updates On Legal Proceedings Against Company
Australia's Monash IVF hits over 9-mth high on upbeat outlook
Brief: Monash IVF Says HY Underlying Profit From Ordinary Activities After Tax Attributable Down 5.7%
Brief: Monash IVF Group Says Note Media Speculation Co May Be Subject Of A Potential Control Transaction
Jefferies says Australia's Monash IVF to increase its market share, raises PT